Genetic information and mutation
DNA stores the sequence of every protein in three-letter codons. Changing a single letter can do nothing, change one amino acid, or stop the protein short. What mutations do, and how often each kind happens, is measurable.
NCBI RefSeq NM_000518.5, coding sequence. Click any base to change, insert or delete it. Changed codons are outlined; amino acids are coloured by side-chain class.
The protein: before and after
- Length
- 147 → 147 amino acids
- Identical residues
- 100%
- Stop codon
- at codon 148
Mutation log
No mutations yet. Click a base, mutate at random, or apply a known variant.
Compare the four kinds, side by side
One example of each kind, chosen automatically from the original sequence:
c.10C>T: codon 4 CTG → TTG (Leu → Leu)- Protein length
- 147 aa
- First change
- none
- Identical residues
- 100%
The codon changes but still codes for the same amino acid. Often called 'silent', though synonymous changes can affect splicing, mRNA stability and translation speed (Chamary et al. 2006).
c.11T>A: codon 4 CTG → CAG (Leu → Gln)- Protein length
- 147 aa
- First change
- residue 4
- Identical residues
- 99.3%
One amino acid is replaced by one with a different side-chain class, e.g. charged to non-polar, as in sickle-cell haemoglobin (Glu → Val).
c.19G>T: codon 7 GAG → TAG (Glu → Stop)- Protein length
- 6 aa (was 147)
- First change
- residue 7
- Identical residues
- 4.1%
A codon becomes a stop codon, so the protein is cut short. In living cells such mRNAs are often destroyed by nonsense-mediated decay.
c.31delG: 1 base deleted- Protein length
- 18 aa (was 147)
- First change
- residue 11
- Identical residues
- 6.8%
An insertion or deletion that is not a multiple of three shifts the reading frame: every codon after it is read differently, usually until an early stop.
Every possible single-base substitution in this gene
All 1,332 possible substitutions in the coding region, sorted by what they do to the protein. This is a property of the genetic code and of the sequence, before any selection. The code's structure means that many errors are synonymous or swap similar amino acids (Freeland & Hurst 1998).
Real mutation spectra favour transitions. κ = 1 treats every change as equally likely.
Which kinds are tolerated is a different question: it depends on where each change falls in the folded protein, and on the organism and environment.
How this works, and what it leaves out
Method
- Translation uses the standard genetic code (NCBI table 1), reading from the first base until the first stop codon.
- A substitution is synonymous if the amino acid is unchanged, nonsense if it creates a stop, stop-loss or start-loss if it removes one, and otherwise missense. Missense changes count as "similar" when both amino acids fall in the same one of four side-chain classes (non-polar, polar, positive, negative). An insertion or deletion is a frameshift unless its length is a multiple of three.
- The β-globin sequence is the RefSeq coding sequence NM_000518.5, fetched from NCBI; the known variants use standard HGVS c. numbering.
- The survey counts all 3 × (coding length) possible substitutions; κ weights transitions relative to transversions.
Limitations
- The coding sequence is shown already spliced; the real HBB gene has two introns, and some variants (HbE, for example) act partly through splicing.
- "Similar side chain" is a coarse four-class rule. Real effects depend on the position in the folded protein, and substitution matrices or experiments are needed to judge them.
- Cellular responses such as nonsense-mediated decay, and effects on regulation, are not modelled.
Weighing the evidence
01 What is observed?
- EstablishedThe standard genetic code assigns 61 codons to 20 amino acids and 3 to 'stop'. It is nearly universal, with a few known variants. (Koonin & Novozhilov 2009)
- EstablishedThe code limits the damage from errors: a mistaken codon usually codes for the same or a similar amino acid. Under one weighting, only about one in a million random alternative codes did better. (Freeland & Hurst 1998)
- EstablishedMutation rates have been measured directly: about 1 × 10⁻³ per genome per generation in E. coli, and 1.2 × 10⁻⁸ per nucleotide per generation in humans. (Lee et al. 2012; Kong et al. 2012)
- EstablishedMost mutations that affect fitness are harmful, and the proportions vary by organism and gene. In one RNA virus up to 40% of random single-base changes were lethal. (Eyre-Walker & Keightley 2007; Sanjuán et al. 2004)
- EstablishedSickle-cell haemoglobin is a single-base change (Glu → Val at position 6). One copy protects against severe malaria; two cause disease. (Ingram 1957; Allison 1954)
- Established'Silent' synonymous changes are not always neutral: they can affect splicing, mRNA stability and translation. (Chamary et al. 2006)
- EstablishedIn Lenski's long-term experiment, one population evolved the ability to grow on citrate in oxygen after tens of thousands of generations, through earlier 'potentiating' mutations followed by a later one. (Blount et al. 2008)
02 What does evolutionary theory propose?
- EstablishedPoint mutation, duplication, rearrangement, recombination and horizontal transfer, filtered by selection and drift, are the sources of new genetic information. Many substitutions are neutral. (Kimura 1968; Eyre-Walker & Keightley 2007)
- SpeculativeThe code's error-minimising structure is itself a product of selection on early codes. (Freeland & Hurst 1998; Koonin & Novozhilov 2009)
03 What are the unresolved questions and criticisms?
- SpeculativeHow the genetic code arose. Stereochemical, coevolution and error-minimisation hypotheses each explain part of the pattern, and none is established. This is an origin-of-life question, not one that natural selection among organisms can answer. (Koonin & Novozhilov 2009)
- Active researchBehe reviewed experimental-evolution studies and argued that most adaptive mutations break or blunt existing genes ('the first rule of adaptive evolution'). Others point to gains such as the citrate innovation and de novo genes. How common gain-of-function adaptation is remains debated. (Behe 2010; Blount et al. 2008; Carvunis et al. 2012)
- Active researchHow long it takes to acquire changes that only work together. Durrett & Schmidt modelled two coordinated changes in a regulatory sequence and found a few million years enough for Drosophila but more than 100 million years for humans. Behe and the authors disagreed in an exchange of letters about what the result implies. (Durrett & Schmidt 2008; Behe 2009)
04 What evidence would help distinguish competing explanations?
- Across many experimental-evolution studies, measured rates of gain-of-function versus loss-of-function adaptive mutations.
- Laboratory evolution of new functions that need several coordinated changes, timed and compared with population-genetics predictions.
- Experimental tests of proposed routes to the genetic code using prebiotic chemistry.
Established Measured or observed repeatedly; not in serious dispute.Active research An open research question, or a claim that specialists still dispute.Speculative A proposed explanation that has not yet been tested directly.
Before you move on
Your notes stay in this browser. Nothing is sent anywhere unless you choose to include them in a link you share.
References
- Allison AC (1954). Protection afforded by sickle-cell trait against subtertian malarial infection. BMJ 1:290–294. doi:10.1136/bmj.1.4857.290
- Behe MJ (2009). Waiting longer for two mutations. Genetics 181:819–820 (letter; with the authors' reply). doi:10.1534/genetics.108.098905
- Behe MJ (2010). Experimental evolution, loss-of-function mutations, and “the first rule of adaptive evolution”. The Quarterly Review of Biology 85:419–445. doi:10.1086/656902
- Blount ZD, Borland CZ, Lenski RE (2008). Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. PNAS 105:7899–7906. doi:10.1073/pnas.0803151105
- Carvunis AR, Rolland T, Wapinski I, et al. (2012). Proto-genes and de novo gene birth. Nature 487:370–374. doi:10.1038/nature11184
- Chamary JV, Parmley JL, Hurst LD (2006). Hearing silence: non-neutral evolution at synonymous sites in mammals. Nature Reviews Genetics 7:98–108. doi:10.1038/nrg1770
- Durrett R, Schmidt D (2008). Waiting for two mutations: with applications to regulatory sequence evolution and the limits of Darwinian evolution. Genetics 180:1501–1509. doi:10.1534/genetics.107.082610
- Eyre-Walker A, Keightley PD (2007). The distribution of fitness effects of new mutations. Nature Reviews Genetics 8:610–618. doi:10.1038/nrg2146
- Freeland SJ, Hurst LD (1998). The genetic code is one in a million. Journal of Molecular Evolution 47:238–248. doi:10.1007/pl00006381
- Ingram VM (1957). Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180:326–328. doi:10.1038/180326a0
- Kimura M (1968). Evolutionary rate at the molecular level. Nature 217:624–626. doi:10.1038/217624a0
- Kong A, Frigge ML, Masson G, et al. (2012). Rate of de novo mutations and the importance of father's age to disease risk. Nature 488:471–475. doi:10.1038/nature11396
- Koonin EV, Novozhilov AS (2009). Origin and evolution of the genetic code: the universal enigma. IUBMB Life 61:99–111. doi:10.1002/iub.146
- Lee H, Popodi E, Tang H, Foster PL (2012). Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. PNAS 109:E2774–E2783. doi:10.1073/pnas.1210309109
- Modiano D, Luoni G, Sirima BS, et al. (2001). Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414:305–308. doi:10.1038/35104556
- Sanjuán R, Moya A, Elena SF (2004). The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. PNAS 101:8396–8401. doi:10.1073/pnas.0400146101
- Thein SL (2013). The molecular basis of β-thalassemia. Cold Spring Harbor Perspectives in Medicine 3:a011700. doi:10.1101/cshperspect.a011700
- Trecartin RF, Liebhaber SA, Chang JC, et al. (1981). β⁰ thalassemia in Sardinia is caused by a nonsense mutation. Journal of Clinical Investigation 68:1012–1017. doi:10.1172/jci110323